AstraZeneca May Up Vaccine Supply to European Union

European Commission President Ursula von der Leyen said that AstraZeneca, the Pharmaceutical company has promised to increase its vaccine supply to the European Union (EU).

AstraZeneca, a Pharmaceutical company has promised to increase its vaccine supply to the European Union (EU), said European Commission President Ursula von der Leyen.

The Anglo-Swedish pharmaceutical company will deliver 9 million additional doses in the first quarter of this year, bringing the total quarterly supply to 40 million, compared to last week's offer, von der Leyen said on Twitter on Sunday, Xinhua news agency reported.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘According to the World Health Organization, about 236 candidate vaccines are still being developed worldwide, of which 63 of them in clinical trials -- in countries including Germany, China, Russia, Britain and the United States.’

The company "will start deliveries one week earlier than scheduled," she added, and it will also expand its manufacturing capacity in Europe.

The message came as a relief after a heated quarrel between the bloc and the company over the latter's limited capacity to deliver on its commitment, after the company announced last week to considerably reduce the amount of doses to the EU.

Media reports revealed that the drug giant had agreed to provide 80 million doses for the first quarter, but withdrew from the promise after an alleged disruption in its EU supply chain.

WHO Experts to Provide Guidelines on Moderna's COVID Vaccine
World Health Organization (WHO) panel of vaccine experts is set to issue recommendations on Moderna's COVID-19 vaccine on Tuesday.

The AstraZeneca was the first vaccine producer that the EU has signed an early purchase agreement with in the effort to prevent the Covid-19 from further spread.

According to the agreement signed last August, the European Commission, on behalf of the EU states, purchased 300 million doses, with an option to buy 100 million more.

Phase 3 Trial of Chinese COVID Vaccine Starts in Malaysia
Malaysia has begun a phase 3 clinical trial of a COVID-19 vaccine candidate developed by the Institute of Medical Biology of the Chinese Academy of Medical Sciences (IMBCAMS).

The AstraZeneca vaccine was approved for conditional marketing in the EU on Friday, after the European Medicines Agency gave a positive assessment for its safety and effectiveness. It was the the third Covid-19 vaccine greenlighted by the EU.

As the world is struggling to contain the pandemic, vaccination is being rolled out across the whole EU with the already-authorized coronavirus vaccines.

World Faces 'Catastrophic Moral Failure' Cause of Covid Vaccine: WHO Chief
World Health Organisation’s (WHO) chief Tedros Adhanom Ghebreyesus said that the world is on the brink of a catastrophic moral failure - and the price of this failure will be paid with lives and livelihoods in the world's poorest countries.

Meanwhile, 236 candidate vaccines are still being developed worldwide -- 63 of them in clinical trials -- in countries including Germany, China, Russia, Britain and the United States, according to information released by the World Health Organization on January 26.

Source-IANS